Clinical Trial Update: Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 study sponsored by the NCI evaluated lapatinib for brain metastases in patients with stage IV HER2-positive breast cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Central Nervous System Metastases
• Male Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Central Nervous System Metastases, HER2-positive Breast Cancer | Phase 2 | Status: COMPLETED